A detailed history of Provident Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Provident Trust CO holds 11,322 shares of ABBV stock, worth $1.99 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,322
Previous 11,070 2.28%
Holding current value
$1.99 Million
Previous $1.9 Million 17.76%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $41,287 - $50,231
252 Added 2.28%
11,322 $2.24 Million
Q3 2021

Nov 02, 2021

SELL
$106.4 - $120.78 $522,211 - $592,788
-4,908 Reduced 30.72%
11,070 $1.19 Million
Q2 2017

Aug 07, 2017

BUY
N/A
15,978
15,978 $1.16 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Provident Trust CO Portfolio

Follow Provident Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Provident Trust CO with notifications on news.